Melody Gayle Duvall, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV-2 | 3 | 2008 | 167 | 0.850 |
Why?
|
Lim Kinases | 1 | 2020 | 10 | 0.760 |
Why?
|
Docosahexaenoic Acids | 4 | 2023 | 875 | 0.640 |
Why?
|
End Stage Liver Disease | 1 | 2022 | 314 | 0.630 |
Why?
|
Cytoskeleton | 1 | 2020 | 1185 | 0.510 |
Why?
|
Killer Cells, Natural | 2 | 2020 | 2133 | 0.480 |
Why?
|
Scurvy | 1 | 2013 | 29 | 0.470 |
Why?
|
Inflammation Mediators | 3 | 2021 | 1889 | 0.430 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1199 | 0.430 |
Why?
|
Heart Arrest | 1 | 2022 | 1470 | 0.410 |
Why?
|
Eicosapentaenoic Acid | 1 | 2015 | 582 | 0.390 |
Why?
|
Liver Transplantation | 1 | 2022 | 2119 | 0.380 |
Why?
|
Informed Consent | 1 | 2017 | 995 | 0.380 |
Why?
|
Neutrophils | 3 | 2021 | 3719 | 0.380 |
Why?
|
Pneumonia | 2 | 2024 | 2133 | 0.360 |
Why?
|
Vitamin D Deficiency | 2 | 2024 | 1343 | 0.360 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2008 | 4386 | 0.350 |
Why?
|
Research | 1 | 2017 | 1999 | 0.330 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2013 | 615 | 0.320 |
Why?
|
Asthma | 4 | 2024 | 6011 | 0.310 |
Why?
|
Inflammation | 6 | 2024 | 10638 | 0.300 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2008 | 880 | 0.270 |
Why?
|
Lung Diseases | 1 | 2015 | 1886 | 0.260 |
Why?
|
HIV-1 | 5 | 2008 | 6939 | 0.220 |
Why?
|
Hypertension, Pulmonary | 1 | 2013 | 1537 | 0.220 |
Why?
|
Neutrophil Activation | 1 | 2021 | 186 | 0.190 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2023 | 139 | 0.190 |
Why?
|
Leukocytes | 2 | 2019 | 2043 | 0.180 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 329 | 0.160 |
Why?
|
Lipoxins | 1 | 2020 | 412 | 0.150 |
Why?
|
Sepsis | 2 | 2021 | 2593 | 0.140 |
Why?
|
Dendritic Cells | 1 | 2007 | 2725 | 0.140 |
Why?
|
Monocytes | 2 | 2021 | 2596 | 0.120 |
Why?
|
Respiratory Mucosa | 1 | 2017 | 427 | 0.120 |
Why?
|
Dexamethasone | 1 | 2020 | 1951 | 0.110 |
Why?
|
Nerve Growth Factors | 1 | 2016 | 574 | 0.110 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2019 | 828 | 0.110 |
Why?
|
Tissue Donors | 1 | 2022 | 2240 | 0.110 |
Why?
|
Respiratory System | 1 | 2016 | 557 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2022 | 1344 | 0.110 |
Why?
|
HIV Infections | 3 | 2008 | 16718 | 0.110 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15540 | 0.100 |
Why?
|
CD4 Lymphocyte Count | 2 | 2007 | 2559 | 0.090 |
Why?
|
T-Lymphocytes | 1 | 2008 | 10180 | 0.090 |
Why?
|
Flow Cytometry | 4 | 2008 | 5974 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2022 | 3864 | 0.080 |
Why?
|
Allergens | 1 | 2016 | 1320 | 0.080 |
Why?
|
Mast Cells | 1 | 2016 | 1544 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1477 | 0.080 |
Why?
|
Interleukin-2 | 2 | 2024 | 1904 | 0.080 |
Why?
|
Cytopathogenic Effect, Viral | 2 | 2005 | 156 | 0.080 |
Why?
|
Humans | 18 | 2024 | 744343 | 0.080 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2008 | 370 | 0.080 |
Why?
|
Animals | 7 | 2024 | 168757 | 0.070 |
Why?
|
Immunophenotyping | 2 | 2008 | 1880 | 0.070 |
Why?
|
Intracellular Fluid | 1 | 2006 | 203 | 0.070 |
Why?
|
HIV Long-Term Survivors | 1 | 2006 | 126 | 0.070 |
Why?
|
Gene Products, gag | 1 | 2006 | 337 | 0.070 |
Why?
|
Risk | 1 | 2017 | 9687 | 0.060 |
Why?
|
Pneumonia, Viral | 1 | 2023 | 3240 | 0.060 |
Why?
|
Cold Temperature | 1 | 2008 | 772 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2017 | 3679 | 0.060 |
Why?
|
Coculture Techniques | 1 | 2007 | 1341 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2008 | 4479 | 0.060 |
Why?
|
Cryopreservation | 1 | 2008 | 670 | 0.060 |
Why?
|
Membrane Glycoproteins | 2 | 2005 | 3768 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2007 | 1284 | 0.050 |
Why?
|
Gene Products, env | 1 | 2002 | 263 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18029 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2013 | 3188 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2021 | 103 | 0.050 |
Why?
|
DNA, Viral | 1 | 2007 | 2225 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2007 | 1348 | 0.050 |
Why?
|
Child | 3 | 2021 | 77709 | 0.050 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2022 | 227 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2007 | 11483 | 0.040 |
Why?
|
Bronchodilator Agents | 1 | 2022 | 502 | 0.040 |
Why?
|
Leukocyte Elastase | 1 | 2019 | 113 | 0.040 |
Why?
|
Th2 Cells | 1 | 2024 | 1061 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 434 | 0.040 |
Why?
|
Fish Oils | 1 | 2022 | 470 | 0.040 |
Why?
|
Principal Component Analysis | 1 | 2021 | 940 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6171 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25043 | 0.040 |
Why?
|
Necrosis | 1 | 2002 | 1643 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2022 | 1743 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2006 | 3206 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2007 | 5524 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2019 | 582 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1588 | 0.030 |
Why?
|
Vitamins | 1 | 2024 | 1622 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2023 | 1222 | 0.030 |
Why?
|
Adolescent | 2 | 2022 | 85781 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2021 | 1607 | 0.030 |
Why?
|
Cell Degranulation | 1 | 2016 | 287 | 0.030 |
Why?
|
Male | 5 | 2022 | 350118 | 0.030 |
Why?
|
Mice | 4 | 2024 | 81183 | 0.030 |
Why?
|
Lymphocytes | 1 | 2023 | 2617 | 0.030 |
Why?
|
Bronchial Hyperreactivity | 1 | 2016 | 319 | 0.030 |
Why?
|
Antigens, CD | 1 | 2005 | 4026 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2022 | 1855 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2006 | 10481 | 0.030 |
Why?
|
Primates | 1 | 2016 | 545 | 0.030 |
Why?
|
Cytokines | 1 | 2008 | 7322 | 0.030 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2016 | 687 | 0.030 |
Why?
|
Adult | 3 | 2021 | 214055 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2023 | 2958 | 0.020 |
Why?
|
Vitamin D | 1 | 2024 | 3223 | 0.020 |
Why?
|
Disease Progression | 1 | 2006 | 13284 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 310 | 0.020 |
Why?
|
Apoptosis | 1 | 2002 | 9727 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2016 | 19229 | 0.020 |
Why?
|
Lung | 1 | 2022 | 9856 | 0.010 |
Why?
|
Mathematics | 1 | 2005 | 728 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9734 | 0.010 |
Why?
|
Gene Products, nef | 1 | 2002 | 110 | 0.010 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 2002 | 94 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.010 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 153 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1836 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14557 | 0.010 |
Why?
|
Jurkat Cells | 1 | 2002 | 743 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12745 | 0.010 |
Why?
|
Cell Death | 1 | 2005 | 1706 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 213383 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18370 | 0.010 |
Why?
|
Viral Envelope Proteins | 1 | 2002 | 635 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23403 | 0.010 |
Why?
|
Cell Survival | 1 | 2008 | 5882 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2002 | 1586 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57776 | 0.010 |
Why?
|
Female | 3 | 2021 | 380194 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2008 | 2988 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 56430 | 0.010 |
Why?
|
Models, Biological | 1 | 2005 | 9583 | 0.010 |
Why?
|
Aged | 1 | 2019 | 163280 | 0.000 |
Why?
|
Mutation | 1 | 2002 | 29786 | 0.000 |
Why?
|